FRIDAY, Jan. 19, 2024 (HealthDay News) — Folks who drop pounds to help control their diabetes receive other substantial heath benefits for all their efforts, a new study says. Substantial weight loss that led to even a short-lived remission in type 2 diabetes also prompted a 40% lower rate inContinue Reading
THURSDAY, Jan. 4, 2024 (HealthDay News) — The U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs. In a quarterly report issued this week, the agency said it is investigating cases of hair loss; aspiration (when food or other objects get into theContinue Reading
TUESDAY, Jan. 2, 2024 (HealthDay News) — Managing diabetes will be a less expensive proposition for more Americans in 2024. Sanofi has officially joined Novo Nordisk and Eli Lilly in lowering the cost of insulin to $35 a month for many patients. The three drugmakers are also drastically lowering the listContinue Reading
WEDNESDAY, Dec. 27, 2023 (HealthDay News) — It may not take as strict a diet as thought to keep type 1 diabetes under control: New Swedish research shows that a moderate low-carb diet still helped people with type 1 diabetes stick to blood-sugar targets. “The study shows that a moderateContinue Reading
THURSDAY, Dec. 21, 2023 (HealthDay News) — Kids who’ve survived cancer face many health challenges, and a heightened risk for diabetes is one of them, new research shows. A team at St. Jude’s Children’s Hospital in Memphis, Tenn., reports that these children have twice the odds of developing prediabetes (aContinue Reading
WEDNESDAY, Dec. 13, 2023 (HealthDay News) — A healthy plant-based diet can reduce a person’s risk of type 2 diabetes by 24%, a new study has found. Eating plenty of fresh fruits, vegetables and whole grains has this protective effect even in people with a genetic predisposition for diabetes orContinue Reading
TUESDAY, Dec. 12, 2023 (HealthDay News) — Many Americans battling diabetes are turning to a new class of injected drugs that includes blockbusters like Ozempic (semaglutide) and Mounjaro (tirzepatide). But a new study finds half of patients who use these “second line” therapies — a class called GLP-1 RAs — quitContinue Reading
MONDAY, Dec. 11, 2023 (HealthDay News) — Folks who take the blockbuster weight-loss med tirzepatide (Zepbound) may regain much of the weight they lost soon after discontinuing it, new research shows. A trial funded by Eli Lilly, the injected drug’s maker, found that “in patients with obesity or overweight, withdrawingContinue Reading
FRIDAY, Dec. 8, 2023 (HealthDay News) — Could blockbuster diabetes and weight-loss meds such as Ozempic, Wegovy, Mounjaro and Zepbound also lower users’ odds for colon cancer? New research suggests they might. All of these medications (and more) fall into a class of diabetes drugs known as glucagon-like peptide-1 receptorContinue Reading
THURSDAY, Dec. 7, 2023 (HealthDay News) — A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with type 1 diabetes maintain their natural ability to produce insulin,Continue Reading